These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 30452451)

  • 1. Selective inhibition of carbonic anhydrase IX over carbonic anhydrase XII in breast cancer cells using benzene sulfonamides: Disconnect between activity and growth inhibition.
    Mboge MY; Chen Z; Wolff A; Mathias JV; Tu C; Brown KD; Bozdag M; Carta F; Supuran CT; McKenna R; Frost SC
    PLoS One; 2018; 13(11):e0207417. PubMed ID: 30452451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolar-potent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII.
    Akocak S; Güzel-Akdemir Ö; Kishore Kumar Sanku R; Russom SS; Iorga BI; Supuran CT; Ilies MA
    Bioorg Chem; 2020 Oct; 103():104204. PubMed ID: 32891000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated carbonic anhydrase isoform IX and XII inhibitory properties of certain isatin-bearing sulfonamides endowed with in vitro antitumor activity towards colon cancer.
    Eldehna WM; Nocentini A; Al-Rashood ST; Hassan GS; Alkahtani HM; Almehizia AA; Reda AM; Abdel-Aziz HA; Supuran CT
    Bioorg Chem; 2018 Dec; 81():425-432. PubMed ID: 30219719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
    Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells.
    Petreni A; Bonardi A; Lomelino C; Osman SM; ALOthman ZA; Eldehna WM; El-Haggar R; McKenna R; Nocentini A; Supuran CT
    Eur J Med Chem; 2020 Mar; 190():112112. PubMed ID: 32044580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies.
    Zengin Kurt B; Sonmez F; Ozturk D; Akdemir A; Angeli A; Supuran CT
    Eur J Med Chem; 2019 Dec; 183():111702. PubMed ID: 31542715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
    Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1,3-Diaryl Triazenes Incorporating Disulfonamides Show Both Antiproliferative Activity and Effective Inhibition of Tumor-associated Carbonic Anhydrases IX and XII.
    Lolak N; Akocak S; Petreni A; Budak Y; Bozgeyik E; Gurdere MB; Ceylan M; Supuran CT
    Anticancer Agents Med Chem; 2024; 24(10):755-763. PubMed ID: 38362678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow synthesis and biological activity of aryl sulfonamides as selective carbonic anhydrase IX and XII inhibitors.
    Rosatelli E; Carotti A; Ceruso M; Supuran CT; Gioiello A
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3422-5. PubMed ID: 24948563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-Substituted and ring opened saccharin derivatives selectively inhibit transmembrane, tumor-associated carbonic anhydrases IX and XII.
    Ivanova J; Carta F; Vullo D; Leitans J; Kazaks A; Tars K; Žalubovskis R; Supuran CT
    Bioorg Med Chem; 2017 Jul; 25(13):3583-3589. PubMed ID: 28416101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.
    Sarikaya B; Ceruso M; Carta F; Supuran CT
    Bioorg Med Chem; 2014 Nov; 22(21):5883-90. PubMed ID: 25267005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of tumor-associated human carbonic anhydrase isozymes IX and XII by a new class of substituted-phenylacetamido aromatic sulfonamides.
    Akdemir A; Güzel-Akdemir O; Scozzafava A; Capasso C; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5228-32. PubMed ID: 23842519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylethynylbenzenesulfonamide regioisomers strongly and selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic isoforms I and II.
    Knaus EE; Innocenti A; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5892-6. PubMed ID: 21852133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substituted benzene sulfonamides incorporating 1,3,5-triazinyl moieties potently inhibit human carbonic anhydrases II, IX and XII.
    Saluja AK; Tiwari M; Vullo D; Supuran CT
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1310-4. PubMed ID: 24507918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors. Synthesis of 2,4,6-trimethylpyridinium derivatives of 2-(hydrazinocarbonyl)-3-aryl-1H-indole-5-sulfonamides acting as potent inhibitors of the tumor-associated isoform IX and XII.
    Güzel O; Maresca A; Scozzafava A; Salman A; Balaban AT; Supuran CT
    Bioorg Med Chem Lett; 2009 Jun; 19(11):2931-4. PubMed ID: 19410461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A class of carbonic anhydrase IX/XII - selective carboxylate inhibitors.
    Alhameed RA; Berrino E; Almarhoon Z; El-Faham A; Supuran CT
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):549-554. PubMed ID: 31967484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: Synthesis, biological and molecular dynamics analysis.
    Abdelrahman MA; Ibrahim HS; Nocentini A; Eldehna WM; Bonardi A; Abdel-Aziz HA; Gratteri P; Abou-Seri SM; Supuran CT
    Eur J Med Chem; 2021 Jan; 209():112897. PubMed ID: 33038795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX.
    Pastorekova S; Casini A; Scozzafava A; Vullo D; Pastorek J; Supuran CT
    Bioorg Med Chem Lett; 2004 Feb; 14(4):869-73. PubMed ID: 15012984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of coumarin-3-carboxamides as selective carbonic anhydrase IX and XII inhibitors.
    Thacker PS; Alvala M; Arifuddin M; Angeli A; Supuran CT
    Bioorg Chem; 2019 May; 86():386-392. PubMed ID: 30763885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.